Orbimed Advisors LLC Standard Biotools Inc. Transaction History

Orbimed Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $10.7 Million - $15.1 Million	-3,819,348 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $2.83 Million - $4.78 Million	-780,223 Reduced 16.96%	3,819,348 $15 Million
Q3 2021 Nov 15, 2021	SELL	$5.5 - $7.41 $342,650 - $461,643	-62,300 Reduced 1.34%	4,599,571 $30.3 Million
Q2 2021 Aug 16, 2021	BUY	$4.35 - $6.35 $271,005 - $395,605	62,300 Added 1.35%	4,661,871 $28.7 Million
Q1 2021 May 17, 2021	BUY	$3.94 - $7.09 $2.79 Million - $5.01 Million	707,225 Added 18.17%	4,599,571 $20.8 Million
Q4 2020 Feb 16, 2021	BUY	$5.45 - $8.65 $1.85 Million - $2.93 Million	338,643 Added 9.53%	3,892,346 $23.4 Million
Q3 2020 Nov 16, 2020	BUY	$4.34 - $11.43 $2.81 Million - $7.39 Million	646,603 Added 22.24%	3,553,703 $26.4 Million
Q2 2020 Aug 14, 2020	BUY	$1.85 - $5.29 $5.38 Million - $15.4 Million	2,907,100 New	2,907,100 $11.7 Million
Q4 2018 Feb 14, 2019	SELL	$7.18 - $8.83 $7.74 Million - $9.52 Million	-1,077,801 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$5.92 - $8.35 $2.99 Million - $4.22 Million	-505,899 Reduced 31.94%	1,077,801 $8.07 Million
Q4 2017 Feb 14, 2018	SELL	$4.46 - $6.45 $724,304 - $1.05 Million	-162,400 Reduced 9.3%	1,583,700 $9.33 Million
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.49 $6.2 Million - $9.59 Million	1,746,100	1,746,100 $8.8 Million

143

274M

6.7K

48.7K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $106M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.